To define the possible effect of tumor monocyte-derived IL-1 on the immunomodulatory reprogramming of EGCs, we isolated tumor- and bone marrow (BM)-derived monocytes from mice bearing orthotopic colon tumors and exposed primary enteric glia to their supernatant with or without IL-1R blockade (Fig. 5a). This evidence concerns the gene IL1A and neoplasm.